Teva
Teva Expands Alvotech Collaboration with 2 New Biosimilar, $40M Investment & Enhanced Oversight
SG Tylor
Source – Teva Pharmaceuticals Following the second FDA rejection of Teva’s Alvotech-partnered biosimilar for Humira, the two companies are expanding ...
Teva Introduces a Smart Inhaler That Could Revolutionize Asthma Management
SG Tylor
Teva has introduced a digitally-enabled inhaler called GoResp Digihaler in the UK, making it the first European market to receive ...
Gilead and Teva were acquitted in a $3.6 billion trial involving alleged ‘pay-for-delay’ schemes
SG Tylor
Gilead Sciences and Teva have been exonerated by a California court jury in a lawsuit accusing them of colluding to ...
Another Stelara patent settlement was reached by J&J, this time with Alvotech and Teva
SG Tylor
Source – Johnson & Johnson By early 2025, a new settlement may allow for the entry of a second biosimilar ...
